PharmaLegacyImmuno-therapy has now been representing a significant paradigm shift in cancer treatment after the promising clinical data from the immune-checkpoint modulators. Profiling anti-cancer drug candidates with clinical relevant humanized mouse model provides fundamental information for oncology research and development. PharmaLegacy offers comprehensive oncology and immuno-oncology drug discovery platform which includes in vivo efficacy evaluation in various validated tumor models (Humanized mouse model, Syngeneic mouse model, CDX, PDX…), target identification and validation, PK/PD and exploratory toxicology to support our global clients/ partners for their portfolio development.is focused on True and effective Humanized mice, humanized mice used by medarex career, Offer the best Humanized mouse model, Humanized mouse model price list of the company and other projects. even though in the rapid development of the project ,PharmaLegacy always stressed the balance between external opportunities and internal management, attaches great importance to the core competitiveness of enterprises to cultivate and shape. Our company take the value of customer service as the core competitiveness of enterprises, adhering to the honesty and integrity , the pursuit of excellence, respect individual for the corporate spirit, and strive to provide customers with integrity and reliable Humanized mouse model.
PharmaLegacyadheres to advance with the times and advocates to the service-oriented,faith-based, people-oriented management idea. With a belief of customer first to forge ahead , company insists on providing our clients with satisfying and best service ofAutoimmuneDiseasesModelx2a3868en,Syngeneic mouse model,